Announcing the release of the second version of the electronic reporting system for adverse drug reaction Announcing the release of the second version of the electronic reporting system for adverse drug reaction Publication Date Applying Date 2013-12-09
Announcing the release of the second version of the electronic reporting system for adverse drug reaction
Announcing the release of the second version of the electronic reporting system for adverse drug reaction
The risk of rhabdomylosis/myopathy associated with the concomitant use of Simvastatin and Gemfibrozil The risk of rhabdomylosis/myopathy associated with the concomitant use of Simvastatin and Gemfibrozil Publication Date Applying Date 2013-12-09
The risk of rhabdomylosis/myopathy associated with the concomitant use of Simvastatin and Gemfibrozil
The risk of rhabdomylosis/myopathy associated with the concomitant use of Simvastatin and Gemfibrozil
Diane-35 and risk of thromboembolism Diane-35 and risk of thromboembolism Publication Date Applying Date 2013-12-09
Possibility of serious adverse events after intravenous administration of pethidine injection Possibility of serious adverse events after intravenous administration of pethidine injection Publication Date Applying Date 2013-12-09
Possibility of serious adverse events after intravenous administration of pethidine injection Possibility of serious adverse events after intravenous administration of pethidine injection Publication Date Applying Date 2013-12-09
Cefepime use and risk of nonconvulsive status epileptics in patients with kidney impairment Cefepime use and risk of nonconvulsive status epileptics in patients with kidney impairment Publication Date Applying Date 2013-12-09
SFDA Statement About The Recent Updates Concerning Safe Use Of Azithromycin SFDA Statement About The Recent Updates Concerning Safe Use Of Azithromycin Publication Date Applying Date 2013-12-09
Updates on Safety Information of Fentanyl Patches (Duragesic®) Updates on Safety Information of Fentanyl Patches (Duragesic®) Publication Date Applying Date 2013-12-09
Saudi Food And Drug Authority Revokes Management of Preterm Labor Indication For Terbutaline Saudi Food And Drug Authority Revokes Management of Preterm Labor Indication For Terbutaline Publication Date Applying Date 2013-12-09
Safety Warning : The Risk of death associated with intravenous administration of undiluted Ranitidine 50 mg/2ml Safety Warning : The Risk of death associated with intravenous administration of undiluted Ranitidine 50 mg/2ml Publication Date Applying Date 2013-12-09
Safety Warning : The Risk of death associated with intravenous administration of undiluted Ranitidine 50 mg/2ml
Safety Warning : The Risk of death associated with intravenous administration of undiluted Ranitidine 50 mg/2ml